Centiva Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Centiva Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,000	Closed	-$1.47M	–	2235
2023 Q2	$1.47M	Buy	+35,000	New	+$1.42M	0.03%	469
2022 Q4	–	Sell	-10,593	Closed	-$499K	–	1739
2022 Q3	$499K	Buy	10,593 +2,782	+36%	+$180K	0.01%	879
2022 Q2	$560K	Buy	+7,811	New	+$571K	0.01%	865
2022 Q1	–	Sell	-2,058	Closed	-$211K	–	1894
2021 Q4	$211K	Buy	+2,058	New	+$198K	﹤0.01%	991
2021 Q3	–	Sell	-5,834	Closed	-$522K	–	1704
2021 Q2	$522K	Buy	+5,834	New	+$493K	0.01%	814
2020 Q1	–	Sell	-16,099	Closed	-$957K	–	972
2019 Q4	$957K	Buy	+16,099	New	+$865K	0.05%	296

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $88.9B AUM 38.03% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $46.7B AUM 50.59% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Centiva Capital's SYNH Position: Q3 2023 in Review

Centiva Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 35,000 shares — an estimated $1.47M sold.

Centiva Capital first reported a position in SYNH in Q4 2019 and held it in 6 quarters. The position peaked at $1.47M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Centiva Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Centiva Capital sold 35,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.47M.
Centiva Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 6 quarters.
Centiva Capital's Syneos Health, Inc. Class A Common Stock position peaked at $1.47M in Q2 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.